Bexson Biomedical
Jeffrey Becker, MD, serves as the Chief Scientific Officer at Bexson Biomedical, Inc. since June 2017, focusing on the development of an innovative ketamine delivery system for pain and mental health disorders. Concurrently, since June 2004, Jeffrey Becker, MD has operated as a Functional Medical Doctor and Psychiatrist, amassing sixteen years of clinical experience in identifying and treating root-cause metabolic, nutrient-based, and genetic mechanisms associated with complex mental health conditions and syndromic illnesses, including schizophrenia, treatment-resistant depression, and various neurological disorders.
This person is not in any teams
This person is not in any offices
Bexson Biomedical
2 followers
Bexson Biomedical is developing non-opioid therapies for pain management. Their goal is to provide therapies that provide relief to patients and reduce the rates of opioid addiction.